Nivolumab in patients with advanced solid tumors with ctDNA-defined high blood tumor mutational burden: a phase II trial

ESMO Open · Elsevier

Аннотация

Publication date: November 2026 Source: ESMO Open, Volume 11, Issue 11 Author(s): Y. Nakamura, T. Esaki, T. Nishina, E. Shinozaki, H. Taniguchi, T. Kato, Y. Komatsu, S. Yuki, K. Kato, M. Wakabayashi, T. Ikeno, Y. Ishiguro, K. Takahashi, Y. Ikeda, M. Asano, A. Sato, T. Kuwata, T. Yoshino

Читать у издателя →

Похожие статьи